Top Markets
Coin of the day
Achilles Therapeutics plc Achilles Therapeutics plc

Achilles Therapeutics plc

ACHL
株式のランク #24575
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused... Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
株価
$1.48
最終同期: 2025-03-24
時価総額
$59.05M
変化(1日)
0.00%
変化(1年)
0.00%
GB
取引 Achilles Therapeutics plc (ACHL)

カテゴリー

Achilles Therapeutics plc(ACHL)の株価履歴
終値の最高値: $1.42 (2025-03-01)

終値の最安値: $16.55 (2021-03-01)
Achilles Therapeutics plc の株価履歴(2021 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2025 35.96%
2024 21.05%
2023 -23.13%
2022 -77.06%
2021 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$547.71 37.80%
US
$1.04K 57.18%
NL
$145.75 455.87%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH